Katherine Lambert
Physician Assistant · Dunkirk, MDNPI 1093855819
Payments from drug & device makers
Across 194 payments — averaging $24.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$583
- Johnson & Johnson$410
- AstraZeneca$243
- E.r. Squibb & Sons, L.L.C.$202
- Merck$193
- Takeda Pharmaceuticals U.S.A., Inc.$182
- plus $3K from 47 others
What the payments were for
- Food & beverage$4,69698%
- Education$802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,776 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 62 | $936,878 |
| PomalystPomalidomide | 26 | $549,936 |
| Lenalidomide | 32 | $452,256 |
| ImbruvicaIbrutinib | 25 | $387,632 |
| PromactaEltrombopag Olamine | 23 | $234,710 |
| KisqaliRibociclib Succinate | 17 | $223,650 |
| BrukinsaZanubrutinib | 13 | $184,661 |
| IbrancePalbociclib | 14 | $183,990 |
| Abiraterone Acetate | 30 | $112,533 |
| XareltoRivaroxaban | 52 | $65,433 |
| EliquisApixaban | 47 | $53,918 |
| OrgovyxRelugolix | 11 | $28,323 |
| Letrozole | 137 | $4,791 |
| Exemestane | 14 | $3,039 |
| Hydroxyurea | 26 | $678 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $47 | $936,87862 claims |
| E.r. Squibb & Sons, L.L.C.Pomalyst | $202 | $549,93626 claims |
| NovartisPromacta, Kisqali | $583 | $458,35940 claims |
| PfizerIbrance, Eliquis | $154 | $237,90861 claims |
| Beigene USA, Inc.Brukinsa | $63 | $184,66113 claims |
| Johnson & JohnsonXarelto | $410 | $65,43352 claims |
| Sumitomo Pharma America, Inc.Orgovyx | $21 | $28,32311 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $50 | $13813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Dunkirk
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Bruce SmithBaltimore$63K
- Shannon MarriottBaltimore$38K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.